Showing results (461-470 of 1,408) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|June 27, 2022
Empirical evidence for biometal dysregulation in Parkinson's disease from a systematic review and Bradford Hill analysisAmr H Abdeen, Benjamin G Trist, Kay L DoubleNPJ Parkinson'S Disease|December 16, 2022
Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohortsAnant Dadu, Vipul Satone, Rachneet Kaur, et al.NPJ Parkinson'S Disease|January 16, 2023
Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activityNagendran Ramalingam, Shan-Xue Jin, Tim E Moors, et al.NPJ Parkinson'S Disease|January 7, 2023
Subthalamic beta bursts correlate with dopamine-dependent motor symptoms in 106 Parkinson's patientsRoxanne Lofredi, Liana Okudzhava, Friederike Irmen, et al.NPJ Parkinson'S Disease|July 8, 2022
Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathwayJingwen Li, Hanshu Liu, Xinyi Wang, et al.NPJ Parkinson'S Disease|January 6, 2021
Multimodal phenotypic axes of Parkinson's diseaseRoss D Markello, Golia Shafiei, Christina Tremblay, et al.NPJ Parkinson'S Disease|July 20, 2021
Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cellsJeong-Eun Yoo, Dongjin R Lee, Sanghyun Park, et al.NPJ Parkinson'S Disease|July 8, 2021
TOMM40 '523' poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson's diseaseMegan C Bakeberg, Anastazja M Gorecki, Abigail L Pfaff, et al.NPJ Parkinson'S Disease|May 13, 2022
Neuropathology of Parkinson's disease after focused ultrasound thalamotomyShunsuke Koga, Mariam Ishaque, W Jeffrey Elias, et al.NPJ Parkinson'S Disease|July 22, 2021
Case-control study of hypertension and Parkinson's diseaseYuen-Fann Ng, Ebonne Ng, Ee-Wei Lim, et al.Pageof 141